英文論文
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
2018
Yoshihide Mitsuda, Ken Morita, Gengo Kashiwazaki, Junichi Taniguchi, Toshikazu Bando, Masahiro Hirata, Moeka Obara, Tatsuki R Kataoka, Manabu Muto,Yasufumi Kaneda, Tatsutoshi Nakahata, Pu Paul Liu, Souichi Adachi, Hiroshi Sugiyama and Yasuhiko Kamikubo.
RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells.
Sci Rep. 2018 Apr 23;8(1):6423.
Tamaoki Masashi, Komatsuzaki Rie, Komatsu Masayuki, Minashi Keiko, Aoyagi Kazuhiko, Nishimura Takao, Chiwaki Fumiko, Hiroki Tomoko, Daiko Hiroyuki, Morishita Kazuhiro, Sakai Yoshiharu, Seno Hiroshi, Chiba Tsutomu, Muto Manabu, Yoshida Teruhiko, Sasaki Hiroki.
Multiple roles of SIM2 in esophageal squamous cell carcinoma and its clinical implications
Cancer Sci. 2018 Apr;109(4):1121-1134.
Hiroki Nagai, Manabu Muto.
Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update
Int J Clin Oncol. 2018 Jun;23(3):410-420.
Tomohiro Kondo, Masashi Kanai, Tadayuki Kou, Tomohiro Sakuma, Hiroaki Mochizuki, Mayumi Kamada, Masahiko Nakatsui, Norimitsu Uza, Yuzo Kodama,Toshihiko Masui, Kyoichi Takaori, Shigemi Matsumoto, Hidehiko Miyake, Yasushi Okuno and Manabu Muto.
Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer.
Oncotarget. 2018 Apr 13;9(28):19817-19825.
Motoo Nomura, Atsushi Otsuka, Michio Yoshimura, Yumi Nonomura, Yo Kaku, Shigemi Matsumoto, Manabu Muto.
Efficacy and safety of concurrent immunoradiotherapy in patients with metastatic melanoma after progression on nivolumab
Cancer Chemother Pharmacol. 2018 May;81(5):823-827.
Yamada A, Yu P, Lin W, Okugawa Y, Boland CR, Goel A.
A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer.
Sci Rep. 2018 Jan 12;8(1):575.
Kanesaka T, Uedo N, Yao K, Ezoe Y, Doyama H, Oda I, Kaneko K, Kawahara Y, Yokoi C, Sugiura Y, Ishikawa H, Takeuchi Y, Arao M, Iwatsubo T, Iwagami H, Matsuno K, Muto M, Saito Y, Tomita Y.
Multiple convex demarcation line for prediction of benign depressed gastric lesions in magnifying narrow-band imaging.
Endosc Int Open. 2018 Feb;6(2):E145-E155.
Hiromasa Yamamoto, Shinichi Toyooka, Takashi Ninomiya, Shigemi Matsumoto, Masashi Kanai, Shuta Tomida, Katsuyuki Kiura, Manabu Muto, Ken Suzawa, Patrice Desmeules, Mark G. Kris, Bob T. Li, Marc Ladanyi.
Therapeutic potential of afatinib for cancers with ERBB2 (HER2) transmembrane domain mutations G660D and V659E
Oncologist. 2018 Feb;23(2):150-154.
Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Eishi Baba, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Yoshifumi Ubara, Hisateru Yasui, Akihiro Yoshimoto, Shingo Fukuma, Naoya Kondo, Takeshi Matsubara, Kazuo Matsubara, Shunichi Fukuhara, Motoko Yanagita, Manabu Muto.
Chemotherapy in cancer patients undergoing hemodialysis: A nationwide study in Japan
ESMO Open 2018 Feb 23;3(2):e000301.